![](/img/cover-not-exists.png)
Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18
J. Douillard, V. Petersen, F. Shepherd, L. Paz-Ares, A. Arnold, M. Tonato, J. Ottaway, M. Davis, A. Van Vreckem, J. Humphrey, L. SeymourVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)80555-4
File:
PDF, 365 KB
english, 2001